19 Comments
User's avatar
Charlie Kirk's avatar

I’m turning 56 this week and blessed in nearly every way but, bro, I’m ready for some psychedelics if they’ll blow out the carbon and get this brain and spirit engine running clean again.

Quoth the Raven's avatar

Oh, in my experience, they do for the brain what a ghost pepper enchilada does for the sinuses...

Charlie Kirk's avatar

That’s one hell of an analogy. How do I get me some brain peppers? No. Seriously. How do I?

Quoth the Raven's avatar

And just think, I could have said asshole instead of sinuses and the analogy would have still worked beautifully...enjoy the holiday.

pretty-red, old guy's avatar

OOOoooh man.

I am dyin' laughing at this thread!

Brandon's avatar

Chris, you’re a homie I saw your comment, your attitude on life is inspiring, the jujitsu work you do is sick, you being genuine is refreshing, many thanks to you for all the articles throughout the years.

rtko's avatar

Big Pharma is going to be trying to figure out how they can use psychedelics to make people dependent on some other class of drugs. The idea of “curing” something is not in their business plan.

Quoth the Raven's avatar

Sadly, you might be right...

Petra Kehr's avatar

GS made an assessment about exactly this question back in 2019. Is developing truely healing (not just treating) Pharmaceuticals beneficial for Pharma companies....

Don't hold your breath. Good for society but against the business model.

rtko's avatar

Maybe we should be using indigenous healers who grew up in cultures steeped in these practices and traditions?

Cbarre's avatar

I agree in principle. Psychedelics have the potential to help people make lasting, sometimes permanent changes, and that doesn’t exactly fit with a business model based on people taking drugs for the rest of their lives.

There could be a lot of money to be made during these buyouts, but what concerns me is what happens after Big Pharma owns them. I don’t trust that a treatment with the potential to actually resolve the underlying problem will always be prioritized when the Pharma profitability model is ongoing treatment. There’s a real possibility that some promising psychedelic therapies could be shelved, deprioritized, or shaped around recurring revenue rather than lasting results.

Mezzanotte's avatar

If they are likely to work, and big pharma shelves them or slow walks them, someone else will start up another company to deliver them (assuming patents don't block it).

Petra Kehr's avatar

FDA will block it. Just check the revolving doors.

badnabor's avatar

What I see is that capital and big pharma have decided on a game plan. I can practically see their narrative now. "Through our rigorous research, and proprietary formulations, our approved psychedelics will cure you". Next will be even more money spent on lobbyists to enact regulations against mom and pop natural producers. The money wouldn't flow otherwise. Another example of our bastardized version of capitalism.

zaporozhe's avatar

2/3rds of America is white and half of those are women, so there's your TAM right there.

pretty-red, old guy's avatar

and!

what a great way to capitalize on the TDS infecting society?!

I recently saw data that young, liberal women have an infection rate(inferring TDS aka mental illness) on the order of 50%+

DFTX

CMPS

ATAI

are the top holdings in PSIL

The Color Of Air's avatar

Makes sense as most of them are psychos anyway. They can "identify" with psychedelics but I am not buying into the hype as most drugs on the market (of any kind) are dangerous and often failures. Look at the true destruction patterns of SSRI's. It is only big pharma, the medical mafia and investors that pretend otherwise.

badnabor's avatar

If it's a choice between Big Pharma's synthesized version or Bubba's hand picked from a cow patty shrooms, I'd pick Bubba's everytime!